Abstract
Recent clinical studies have demonstrated the capacity of immunosuppressive therapy to delay progression of inflammatory insulitis in type 1 diabetes (T1D). The procedure includes depletion of pathogenic cells by immunosuppressive therapy and support of recovery by reinfusion of autologous hematopoietic progenitors. The short-term outcome of these clinical transplants is similar to the predictions drawn from NOD mice: debulking of diabetogenic cells is ineffectively achieved by immunosuppressive therapy, and resetting of immune homeostasis does not restrain autoimmunity. Murine models indicate that allogeneic transplants are potentially curative, through restored mechanisms of negative regulation that are effective in continuous and indefinite suppression of autoimmunity.
Keywords: Activation induced cell death, autoimmunity, Fas cross-linking, inflammation, regulatory T cells.
Current Stem Cell Research & Therapy
Title:Hematopoietic Transplants for Disease Suppression and Cure in Type 1 Diabetes
Volume: 8 Issue: 4
Author(s): Nadir Askenasy
Affiliation:
Keywords: Activation induced cell death, autoimmunity, Fas cross-linking, inflammation, regulatory T cells.
Abstract: Recent clinical studies have demonstrated the capacity of immunosuppressive therapy to delay progression of inflammatory insulitis in type 1 diabetes (T1D). The procedure includes depletion of pathogenic cells by immunosuppressive therapy and support of recovery by reinfusion of autologous hematopoietic progenitors. The short-term outcome of these clinical transplants is similar to the predictions drawn from NOD mice: debulking of diabetogenic cells is ineffectively achieved by immunosuppressive therapy, and resetting of immune homeostasis does not restrain autoimmunity. Murine models indicate that allogeneic transplants are potentially curative, through restored mechanisms of negative regulation that are effective in continuous and indefinite suppression of autoimmunity.
Export Options
About this article
Cite this article as:
Askenasy Nadir, Hematopoietic Transplants for Disease Suppression and Cure in Type 1 Diabetes, Current Stem Cell Research & Therapy 2013; 8 (4) . https://dx.doi.org/10.2174/1574888X113089990001
DOI https://dx.doi.org/10.2174/1574888X113089990001 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Management of Type-1 and Type-2 Diabetes by Insulin Injections in Diabetology Clinics - A Scientific Research Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Human Islet Transplantation: Current Status and Future Direction
Micro and Nanosystems Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design Challenges for Gene Therapy of Type 1 Diabetes
Current Gene Therapy Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases
Mini-Reviews in Medicinal Chemistry EDITORIAL (Thematic Issue: Retinal Neurodegeneration in the Course of Diabetes: Neuroprotection as a Potential Treatment Target)
Current Neuropharmacology Anti-HCV Prevalence among Diabetic and Non-Diabetic Egyptian Children
Current Diabetes Reviews Overview of Current and Upcoming Strategies Implied for the Therapy of Type 2 Diabetes Mellitus
Current Diabetes Reviews An Approach to Diabetic Ketoacidosis in an Emergency Setting
Reviews on Recent Clinical Trials COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region
Current Diabetes Reviews Extracellular Hsp70: Export and Function
Current Protein & Peptide Science Structure-Function Relationships and Clinical Applications of L-Asparaginases
Current Medicinal Chemistry Prevalence of Diabetes Ketoacidosis Rises and Still No Strict Treatment Adherence
Current Diabetes Reviews Homeostasis and Compensatory Homeostasis: Bridging Western Medicine and Traditional Chinese Medicine
Current Cardiology Reviews The Correlated Factors of Serum CA19-9 Levels in Diabetic Patients
Current Diabetes Reviews The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Current Pharmaceutical Design Dietary Management of Gestational Diabetes Mellitus
Current Nutrition & Food Science Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine Brittle Type 1 Diabetes Mellitus
Current Medicinal Chemistry